Orbital Therapeutics

Closed

RNA medicines built around disease biology

Cambridge, United States · Founded 2022 · $270.0M raised

Employees
51–200
Founded
2022
Business Model
B2B
Total Funding
$270.0M
Last Round
$270.0M Series AApr 2023
Rounds
1

About

Orbital Therapeutics is advancing a new generation of RNA medicines designed to reprogram cells in vivo, treating diseases at their source. Using a comprehensive set of RNA tools and technologies, the company creates therapies with precision and flexibility to address the underlying biology of immune-driven diseases. Orbital was acquired by Bristol Myers Squibb in October 2025 for $1.5 billion.

Summary

Orbital Therapeutics is a Healthcare company based in Cambridge, United States, founded in 2022. It has raised $270.0M in total across 1 round, most recently a $270.0M Series A round in Apr 2023. Investors include ARCH Venture Partners and Andreessen Horowitz.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2023
$270.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Orbital Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/orbital-therapeutics"><img src="https://indexed.vc/api/badge/company/orbital-therapeutics" alt="Orbital Therapeutics on Indexed.vc" width="260" height="76" /></a>